Ethidrugs Research Lab Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.17 Cr
as on 24-10-2024
- Revenue 1.85%
(FY 2023)
- Profit -76.33%
(FY 2023)
- Ebitda 29.57%
(FY 2023)
- Net Worth 4.70%
(FY 2023)
- Total Assets 9.69%
(FY 2023)
About Ethidrugs Research Lab
The Corporate was formerly known as Alk-Chem Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.17 Cr.
Sumathy Thangarajan and Arigo serve as directors at the Company.
- CIN/LLPIN
U24239PY2009PTC002340
- Company No.
002340
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2009
- Date of AGM
14 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ethidrugs Research Lab Private Limited offer?
Ethidrugs Research Lab Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Biocides, Sexual Wellness Products, Fertility Enhancer, Animal Medicines & Health Care, Veterinary Medicines, Hand Sanitizers & Personal Hygiene, Organic Soap, Hand Wash, Bath Tools.
Who are the key members and board of directors at Ethidrugs Research Lab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumathy Thangarajan  | Director | 30-Mar-2011 | Current |
| Arigo | Director | 20-Jan-2021 | Current |
Financial Performance of Ethidrugs Research Lab.
Ethidrugs Research Lab Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.85% increase. The company also saw a substantial fall in profitability, with a 76.33% decrease in profit. The company's net worth moved up by a moderate rise of 4.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ethidrugs Research Lab?
In 2023, Ethidrugs Research Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 23 Dec 2021 | ₹1.00 Cr | Open |
Others Creation Date: 05 Jul 2021 | ₹2.41 Cr | Open |
Others Creation Date: 01 Jun 2020 | ₹1.05 M | Open |
How Many Employees Work at Ethidrugs Research Lab?
Ethidrugs Research Lab has a workforce of 17 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ethidrugs Research Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ethidrugs Research Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
